| Dr Eric Matthew Foss, DDS, MS | |
|
4 West Dr, Suite 160, Chesterfield, MO 63017-1793 | |
| (636) 778-9901 | |
| Not Available |
| Full Name | Dr Eric Matthew Foss |
|---|---|
| Gender | Male |
| Speciality | Dentist - Endodontics |
| Location | 4 West Dr, Chesterfield, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093853145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223E0200X | Dentist - Endodontics | 2005015009 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Matthew Foss, DDS, MS 4 West Dr, Suite 160, Chesterfield, MO 63017-1793 Ph: (636) 778-9901 | Dr Eric Matthew Foss, DDS, MS 4 West Dr, Suite 160, Chesterfield, MO 63017-1793 Ph: (636) 778-9901 |
News Archive
Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.
The Marshall University School of Pharmacy, in collaboration with the Marshall University Joan C. Edwards School of MedicineGenomics Core, recently released a new study that explores human T cell function under inflammatory conditions.
The popular drug dutasteride may not be a cost-effective way to prevent prostate cancer in men who are at elevated risk of developing the disease, according to findings by a UT Southwestern Medical Center researcher.
Fake social media accounts already have a reputation of swaying political discourse, but a Keck School of Medicine of USC researcher says these automated accounts are even more dangerous - they can be bad for your health.
TxCell SA, a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Col-Treg, its second therapeutic candidate from its ASTrIA platform, has been granted Advanced Therapy Medicinal Product (ATMP) classification by the Committee for Advanced Therapies (CAT) of the European Medicines Agency.
› Verified 1 days ago
Dr. Ronald James Sherstoff, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2 West Dr, Chesterfield, MO 63017 Phone: 636-777-7100 Fax: 636-777-4414 | |
Robert Emil Beck, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 2319 Westpar Dr, Chesterfield, MO 63017 Phone: 636-207-5800 | |
Dr. Terence Leung, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 13371 Olive Blvd, Chesterfield, MO 63017 Phone: 314-878-5544 Fax: 314-878-5544 | |
Dr. Daniel Wray Charpentier, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 14377 Woodlake Dr, 210, Chesterfield, MO 63017 Phone: 314-878-1114 Fax: 314-878-8681 | |
Eric Egan, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 15817 Fountain Plaza Dr, Chesterfield, MO 63017 Phone: 636-220-1104 | |
Dr. David E. Urbanek, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 17300 Outer Forty Road North, Suite 103, Chesterfield, MO 63005 Phone: 636-536-5158 Fax: 636-536-4544 | |
Dr. Carissa Bruening, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 130 Hilltown Village Ctr, Chesterfield, MO 63017 Phone: 636-532-3311 |